Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q7TH
|
||||
Former ID |
DIB008172
|
||||
Drug Name |
BMS-181885
|
||||
Synonyms |
3-[3-[3-[4-(5-Methoxypyrimidin-4-yl)piperazin-1-yl]propyl]-1H-indol-5-ylamino]-4-methyl-3-cyclobutene-1,2-dione
|
||||
Indication | Migraine [ICD9: 346; ICD10:G43] | Terminated | [546243] | ||
Structure |
Download2D MOL |
||||
CAS Number |
CAS 165250-52-2
|
||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 1D receptor | Target Info | Agonist | [525577], [551730] | |
References | |||||
Ref 525577 | Sensitive triple-quadrupole mass spectrometric assay for the determination of BMS-181885, a 5-HT1 agonist, in human plasma following solid phase extraction. Biomed Chromatogr. 1999 Oct;13(6):425-30. | ||||
Ref 551730 | Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors. . The Journal of Headache and Pain 201314(Suppl 1):P75. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.